ComplianceOnline

FDA Draft Guidance on Evaluation of Sex Differences in Medical Device Clinical Studies

  • By: www.fda.gov
  • Date: December 29, 2011
Webinar All Access Pass Subscription Abstract:

The FDA has issued a draft guidance that aims at increasing the representation of women in medical device clinical trials. Aimed at medical device manufacturers and developers, the guidance outlines agency recommendations for designing and conducting device clinical studies that may enhance the enrollment of women in such studies, if appropriate.

Bookmark and Share

Compliance Trainings

Risk Based Monitoring for GCP Compliance
By - Laura Brown
On Demand Access Anytime

Compliance Standards

Best Sellers
You Recently Viewed
    Loading